SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent (“LOI”) with Global Digital ...

Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that it has entered into a non-binding letter of intent dated ...

On Tuesday, Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and off-the-shelf peptide vaccines for cancer patients.

Vincerx Pharma (VINC) announced that it has terminated the previously announced non-binding letter of intent with Global Digital Holdings, conducting business as QumulusAI, regarding a potential ...

April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital ...

further to the announcement on 31 December 2024 to grant a final extension of exclusivity to TheoremRx Inc ("TheoremRx") under the letter of intent ("LOI") until 31 May 2025, the Company has ...

The motion to sign a letter of intent with Junior Achievement was approved, 5-2, during the regular meeting of directors on Tuesday, April 8. The board said the initiative offers equal access and ...

KAILUA-KONA, Hawaii, March 21, 2025 /PRNewswire/ -- The Daniel R. Sayre Memorial Foundation, Inc. has signed a Letter of Intent (LOI) with Life Flight Network, LLC to expand air medical services ...

Under the letter of intent, VERDI has granted Anixa a six-month exclusive right to negotiate a transaction for the research, development, and commercialization of VERDI's cancer vaccines.